Medicare Enrolled
Dr. Bincy Abraham, MD
Gastroenterology · Houston, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abraham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abraham?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abraham
Dr. Bincy Abraham is a gastroenterology specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Abraham performed 61,717 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Abraham received a total of $1,606,768 from 56 pharmaceutical and/or device companies across 2287 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abraham is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 0% volume in TX
$1,606,768 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗61,717
Medicare services
Top 0% in TX for gastroenterology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
39,000 | $16 | $85 |
| Ustekinumab, for intravenous injection, 1 mg | 16,640 | $10 | $22 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
5,320 | $26 | $164 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
244 | $94 | $587 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
188 | $61 | $211 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
66 | $95 | $314 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
57 | $98 | $401 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
44 | $95 | $479 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
44 | $28 | $350 |
| Ultrasound of abdomen and pelvis blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis. |
44 | $111 | $884 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
38 | $46 | $291 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
32 | $111 | $1,318 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
72.3% high complexity
27.2% medium
0.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,606,768
Total received (2018-2024)
Avg $229,538/year across 7 years
Top 0% in TX for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
2,287
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$236,742
2023
$337,203
2022
$297,424
2021
$201,277
2020
$115,791
2019
$223,149
2018
$195,182
Payments by company (2024)
Lilly USA, LLC
$38,400
Takeda Pharmaceuticals U.S.A., Inc.
$36,565
E.R. Squibb & Sons, L.L.C.
$35,931
Celltrion USA Inc.
$26,865
PFIZER INC.
$25,753
ABBVIE INC.
$23,274
Janssen Biotech, Inc.
$20,745
Celltrion Healthcare Canada Ltd.
$12,271
Fresenius Kabi USA, LLC
$4,898
Ferring Pharmaceuticals Inc.
$3,720
Canon Medical Systems USA, Inc.
$2,859
UCB, Inc.
$2,310
Abbott Laboratories
$1,049
Celgene Corporation
$707
Janssen Scientific Affairs, LLC
$666
Johnson & Johnson Health Care Systems Inc.
$229
Regeneron Healthcare Solutions, Inc.
$158
GENZYME CORPORATION
$145
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$70
Merck Sharp & Dohme LLC
$63
Phathom Pharmaceuticals, Inc.
$30
SHIELD THERAPEUTICS INC
$18
Braintree Laboratories, Inc.
$16
Top 3 companies account for 46.8% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$274,667
AbbVie Inc.
$249,497
Takeda Pharmaceuticals U.S.A., Inc.
$213,747
Janssen Scientific Affairs, LLC
$170,055
E.R. Squibb & Sons, L.L.C.
$155,990
Janssen Biotech, Inc.
$109,495
ABBVIE INC.
$106,241
Lilly USA, LLC
$96,596
UCB, Inc.
$61,284
AbbVie, Inc.
$53,810
Celltrion USA Inc.
$29,715
Eli Lilly and Company
$16,927
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15,565
Celltrion Healthcare Canada Ltd.
$12,271
Ferring Pharmaceuticals Inc.
$10,109
Celgene Corporation
$5,413
Fresenius Kabi USA, LLC
$4,914
Janssen Global Services, LLC
$4,445
Canon Medical Systems USA, Inc.
$2,859
Covidien LP
$2,629
UCB SA
$1,770
Quidel Corporation
$1,500
Abbott Laboratories
$1,049
Samsung Bioepis Co., Ltd.
$1,000
Pharmacosmos Therapeutics Inc.
$819
Celltrion Healthcare Co., Ltd
$700
AMAG Pharmaceuticals, Inc.
$500
Prometheus Laboratories Inc.
$400
Johnson & Johnson Health Care Systems Inc.
$354
Biogen, Inc.
$300
Regeneron Healthcare Solutions, Inc.
$298
GENZYME CORPORATION
$233
Synergy Pharmaceuticals Inc
$186
Amgen Inc.
$172
PENTAX of America, Inc.
$151
Ferring International Pharmascience Center US
$125
Shire North American Group Inc
$105
Ardelyx, Inc.
$101
Merck Sharp & Dohme LLC
$95
Braintree Laboratories, Inc.
$92
Medtronic, Inc.
$71
Janssen Pharmaceuticals, Inc
$70
Olympus America Inc.
$66
Intercept Pharmaceuticals, Inc.
$57
QOL Medical, LLC
$50
Daiichi Sankyo Inc.
$50
Ironwood Pharmaceuticals, Inc
$35
Phathom Pharmaceuticals, Inc.
$30
LivaNova USA, Inc.
$28
Siemens Medical Solutions USA, Inc.
$25
Alcresta Therapeutics, Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
SHIELD THERAPEUTICS INC
$18
Blueprint Medicines Corporation
$18
Cook Medical LLC
$17
Shionogi Inc
$12
Top 3 companies account for 45.9% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AMJEVITA · APRISO · AVSOLA · Barrx · CARDIOMEMS · CIMZIA · CLENPIQ · CREON · CYLTEZO · Cimzia · Creon · DARZALEX · DIAGNOSTIC ULTRASOUND SYSTEM · DIFICID · DUPIXENT · ENTYVIO · EOHILIA · EUCRISA · Entyvio · FERAHEME · GATTEX · HUMIRA · Humira · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · INSTINCT · LINZESS · Linzess · MONOFERRIC · ManoScan · Mulpleta · OCALIVA · OMVOH · Olympus Hemostasis Devices · PILLCAM · PLENVU · PillCam · QuickVue · REBYOTA · RELISTOR · RELISTOR ORAL · RELIZORB · REMICADE · RENFLEXIS · RINVOQ · SIMPONI · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP BOWEL PREP · SUTAB · Sequoia · Small Bowel · Smart Pill · Sucraid · TALTZ · TREMFYA · TRULANCE · TYSABRI · Trulance · UCERIS · VEGZELMA · VELSIPITY · VIBERZI · VISIGLIDE · VNS Therapy · VOQUEZNA · XELJANZ · XIFAXAN · ZEPOSIA · ZYMFENTRA · ZYTIGA · Zymfentra
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
251
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Abraham is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Abraham experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Abraham performed 39,000 vedolizumab infusion (entyvio) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Abraham receive payments from pharmaceutical companies?
Yes. Dr. Abraham received a total of $1,606,768 from 56 companies across 2,287 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abraham's costs compare to other gastroenterologists in Houston?
Dr. Abraham's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abraham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Houston
Browse gastroenterologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in TX
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in TX
Which TX gastroenterologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology